| Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer. (NCT07369791) | National Health Research Institutes, Taiwan | 2026-12-01 |
| Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy Device (NCT07764107) | National Health Research Institutes, Taiwan | 2026-08-01 |
| Quantitative Monitoring of Disability Care Quality for Long-Term Care Facilities 2 (NCT07579832) | National Health Research Institutes, Taiwan | 2026-05-15 |
| Social Prescribing Intervention for Health Promotion in Community-Dwelling Older Adults (NCT07540117) | National Health Research Institutes, Taiwan | 2026-04-14 |
| Adult Disease Risk Prediction Using Wearables, Hearing, and Health Data (NCT07541547) | National Health Research Institutes, Taiwan | 2026-01-09 |
| Internet-Based Cognitive Behavioral Therapy With Treatment as Usual for Generalized Anxiety Disorder and Major Depressive Disorder in Taiwan (ICBT-TW) (NCT07177365) | National Health Research Institutes, Taiwan | 2025-09-20 |
| Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy (NCT07151326) | National Health Research Institutes, Taiwan | 2025-09-01 |
| Taiwanese Anaplastic Thyroid Cancer Registry (NCT07138261) | National Health Research Institutes, Taiwan | 2025-09-01 |
| Plant-based Diets and Healthy Aging (NCT07151365) | National Health Research Institutes, Taiwan | 2025-09-01 |
| Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies (NCT05613621) | National Health Research Institutes, Taiwan | 2025-08-14 |
| Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET (NCT05385861) | National Health Research Institutes, Taiwan | 2025-08-14 |
| Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan Urban and Rural Areas (NCT07186023) | National Health Research Institutes, Taiwan | 2025-08-01 |
| The Effects of a Meditation Intervention on the Psychological Burden of Long-Term Care Professionals and Family Caregivers (NCT07188454) | National Health Research Institutes, Taiwan | 2025-05-01 |
| Precision Vibration Therapy for Neuromuscular and Functional Improvement in Older Adults and Stroke Survivors (NCT07351877) | National Health Research Institutes, Taiwan | 2024-09-18 |
| Chronic Wounds and Blood Circulation Detection (NCT07330635) | National Health Research Institutes, Taiwan | 2024-09-04 |
| Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . (NCT05927857) | National Health Research Institutes, Taiwan | 2024-04-01 |
| Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET) (NCT06271200) | National Health Research Institutes, Taiwan | 2024-03-14 |
| The Registry of Genetic Alterations of Taiwan Ovarian Cancer (NCT06127446) | National Health Research Institutes, Taiwan | 2023-12-13 |
| Neoantigen Derived DCs as Cancer Treatment (NCT05767684) | National Health Research Institutes, Taiwan | 2023-06-01 |
| The Registry of Genetic Expression of Taiwan Urologic Cancer (NCT05725304) | National Health Research Institutes, Taiwan | 2023-01-07 |
| A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma (NCT05622409) | National Health Research Institutes, Taiwan | 2022-12-29 |
| The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan (NCT05522881) | National Health Research Institutes, Taiwan | 2022-11-25 |
| The Registry Study of Genetic Alterations of Melanoma in Taiwan (NCT06952400) | National Health Research Institutes, Taiwan | 2022-08-22 |
| Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment (NCT05170438) | National Health Research Institutes, Taiwan | 2022-07-01 |
| Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas (NCT05105412) | National Health Research Institutes, Taiwan | 2022-06-15 |
| A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer (NCT05026905) | National Health Research Institutes, Taiwan | 2021-12-28 |
| The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer (NCT05036486) | National Health Research Institutes, Taiwan | 2021-10-25 |
| The Registry Study of Genetic Alterations of Esophageal Cancer in Taiwan (NCT04996095) | National Health Research Institutes, Taiwan | 2021-10-01 |
| Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients (NCT04821895) | National Health Research Institutes, Taiwan | 2021-08-28 |
| BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study) (NCT04839471) | National Health Research Institutes, Taiwan | 2021-08-06 |
| The Research Plan of Taiwan Precision Medicine (NCT04849481) | National Health Research Institutes, Taiwan | 2021-06-23 |
| A Phase I/II Study of Diffuse Large B-cell Lymphoma (NCT04856137) | National Health Research Institutes, Taiwan | 2021-05-01 |
| Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma. (NCT04688151) | National Health Research Institutes, Taiwan | 2021-02-22 |
| Genomics and Prognosis in GI Cancers (NCT05767697) | National Health Research Institutes, Taiwan | 2020-04-15 |
| Atezolizumab Plus Bevacizumab With HCC and HBV Infection (NCT04180072) | National Health Research Institutes, Taiwan | 2020-03-12 |
| Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model (NCT04203654) | National Health Research Institutes, Taiwan | 2020-02-24 |
| NGS as the First-line Treatment in Advanced Biliary Tract Cancer (NCT04172402) | National Health Research Institutes, Taiwan | 2019-12-27 |
| Home-based Longitudinal Investigation of the Multidisciplinary Team Integrated Care (NCT04250103) | National Health Research Institutes, Taiwan | 2019-11-20 |
| Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA (NCT03544099) | National Health Research Institutes, Taiwan | 2019-05-07 |
| Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC) (NCT03510871) | National Health Research Institutes, Taiwan | 2019-02-12 |
| Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy (NCT03712397) | National Health Research Institutes, Taiwan | 2018-12-24 |
| Observational Registry Data on GIST Patients (NCT03602092) | National Health Research Institutes, Taiwan | 2018-10-16 |
| Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers (NCT03162510) | National Health Research Institutes, Taiwan | 2018-06-26 |
| Locally Advanced or Metastatic Pancreatic Adenocarcinoma (NCT03559348) | National Health Research Institutes, Taiwan | 2018-04-03 |
| SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer (NCT03443492) | National Health Research Institutes, Taiwan | 2018-03-26 |